Molecular Human Reproduction, Vol. 9, No. 5, 301-307,
May 2003
© 2003 European Society of Human Reproduction and Embryology
Article |
An evaluation of PGD in clinical genetic services through 3 years application for prevention of ß-thalassaemia major and sickle cell thalassaemia
Submitted on October 17, 2002; accepted on February 8, 2003
1 Medical Genetics, Athens University and 2 Athens University Research Institute for Prevention and Treatment of Genetic and Malignant Diseases of Childhood, St Sophia’s Children’s Hospital, Athens 11527 and 3 Embryogenesis, Centre for Reproductive and Fertility Studies, Athens 15125, Greece 4 Present address: IVF Clinic, Mitera Maternity Hospital, Athens 15123, Greece
5 To whom correspondence should be addressed. e-mail: ekanavak{at}cc.uoa.gr
PGD represents an alternative within prenatal diagnosis services, which avoids terminating affected on-going pregnancies. In Greece, prevention programmes for haemoglobinopathies, including the option of prenatal diagnosis, are well established. Following optimization of a single-cell genotyping strategy (designed to be applicable for the majority of ß-thalassaemia major or sickle thalassaemia genotype interactions) along with close collaboration with an IVF unit, we integrated the option of PGD for at-risk couples with a problematic reproductive history. A total of 59 couples requesting PGD were counselled, of whom 41 initiated 63 PGD cycles. Following standard assisted reproduction treatment for oocyte retrieval, 20 cycles were cancelled (too few oocytes and/or poor quality embryos), but in 43 cycles single blastomeres were biopsied from 3 day embryos and genotyped (total 302). Diagnosis was achieved for 236 embryos, and 100 of 125 unaffected embryos were transferred. Sixteen pregnancies were established, although six were lost within the first trimester. Ten pregnancies underwent second trimester prenatal diagnosis, with nine pregnancies (13 babies: six singletons, two twins and one triplet) confirmed unaffected, although one singleton was a PGD misdiagnosis and terminated. The triplet pregnancy was selectively reduced to twins, and nine pregnancies went to term, with 12 healthy babies born. This report highlights advantages, limitations and approaches towards improvement when incorporating PGD within genetic services for a common recessive disease.
Key words: ß-thalassaemia major and HbS/genetic services/PGD/prenatal diagnosis
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Kokkali, J. Traeger-Synodinos, C. Vrettou, D. Stavrou, G.M. Jones, D.S. Cram, E. Makrakis, A.O. Trounson, E. Kanavakis, and K. Pantos Blastocyst biopsy versus cleavage stage biopsy and blastocyst transfer for preimplantation genetic diagnosis of beta-thalassaemia: a pilot study Hum. Reprod., May 1, 2007; 22(5): 1443 - 1449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Fiorentino, A. Biricik, A. Nuccitelli, R. De Palma, S. Kahraman, M. Iacobelli, V. Trengia, D. Caserta, M.A. Bonu, A. Borini, et al. Strategies and clinical outcome of 250 cycles of Preimplantation Genetic Diagnosis for single gene disorders Hum. Reprod., March 1, 2006; 21(3): 670 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Kokkali, C. Vrettou, J. Traeger-Synodinos, G.M. Jones, D.S. Cram, D. Stavrou, A.O. Trounson, E. Kanavakis, and K. Pantos Birth of a healthy infant following trophectoderm biopsy from blastocysts for PGD of {beta}-thalassaemia major: Case report Hum. Reprod., July 1, 2005; 20(7): 1855 - 1859. [Abstract] [Full Text] [PDF]
|
|